nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Fluorouracil—head and neck cancer	0.236	0.346	CbGbCtD
Ezetimibe—ABCC2—Vinblastine—head and neck cancer	0.0994	0.146	CbGbCtD
Ezetimibe—ABCG2—Fluorouracil—head and neck cancer	0.097	0.142	CbGbCtD
Ezetimibe—ABCC2—Docetaxel—head and neck cancer	0.082	0.12	CbGbCtD
Ezetimibe—ABCG2—Docetaxel—head and neck cancer	0.0741	0.108	CbGbCtD
Ezetimibe—ABCB1—Vinblastine—head and neck cancer	0.0324	0.0474	CbGbCtD
Ezetimibe—ABCB1—Docetaxel—head and neck cancer	0.0267	0.0391	CbGbCtD
Ezetimibe—Dermatomyositis—Hydroxyurea—head and neck cancer	0.0195	0.141	CcSEcCtD
Ezetimibe—CYP3A4—Vinblastine—head and neck cancer	0.0194	0.0284	CbGbCtD
Ezetimibe—CYP3A4—Docetaxel—head and neck cancer	0.016	0.0234	CbGbCtD
Ezetimibe—Memory loss—Fluorouracil—head and neck cancer	0.00501	0.0362	CcSEcCtD
Ezetimibe—SOAT1—exocrine gland—head and neck cancer	0.00345	0.117	CbGeAlD
Ezetimibe—SOAT1—hair follicle—head and neck cancer	0.00328	0.111	CbGeAlD
Ezetimibe—Foetor hepaticus—Docetaxel—head and neck cancer	0.00187	0.0135	CcSEcCtD
Ezetimibe—SOAT1—parotid gland—head and neck cancer	0.00179	0.0608	CbGeAlD
Ezetimibe—SOAT1—saliva-secreting gland—head and neck cancer	0.00172	0.0583	CbGeAlD
Ezetimibe—ANPEP—parotid gland—head and neck cancer	0.00172	0.0582	CbGeAlD
Ezetimibe—Hepatic failure—Hydroxyurea—head and neck cancer	0.00165	0.012	CcSEcCtD
Ezetimibe—ANPEP—saliva-secreting gland—head and neck cancer	0.00164	0.0557	CbGeAlD
Ezetimibe—SOAT1—connective tissue—head and neck cancer	0.00158	0.0535	CbGeAlD
Ezetimibe—Liver disorder—Docetaxel—head and neck cancer	0.00156	0.0113	CcSEcCtD
Ezetimibe—Inflammation—Fluorouracil—head and neck cancer	0.00152	0.011	CcSEcCtD
Ezetimibe—ANPEP—connective tissue—head and neck cancer	0.00151	0.0512	CbGeAlD
Ezetimibe—Interstitial lung disease—Docetaxel—head and neck cancer	0.0015	0.0109	CcSEcCtD
Ezetimibe—ANPEP—epithelium—head and neck cancer	0.00143	0.0486	CbGeAlD
Ezetimibe—Breast disorder—Hydroxyurea—head and neck cancer	0.00134	0.00971	CcSEcCtD
Ezetimibe—ANPEP—trachea—head and neck cancer	0.00127	0.043	CbGeAlD
Ezetimibe—Pancreatitis—Hydroxyurea—head and neck cancer	0.00126	0.0091	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00123	0.0089	CcSEcCtD
Ezetimibe—Photosensitivity—Fluorouracil—head and neck cancer	0.00122	0.0088	CcSEcCtD
Ezetimibe—Bone disorder—Docetaxel—head and neck cancer	0.00118	0.00851	CcSEcCtD
Ezetimibe—Drug interaction—Docetaxel—head and neck cancer	0.00115	0.00829	CcSEcCtD
Ezetimibe—Infestation NOS—Hydroxyurea—head and neck cancer	0.00114	0.00828	CcSEcCtD
Ezetimibe—Infestation—Hydroxyurea—head and neck cancer	0.00114	0.00828	CcSEcCtD
Ezetimibe—Amnesia—Fluorouracil—head and neck cancer	0.00114	0.00823	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00112	0.00811	CcSEcCtD
Ezetimibe—Pharyngitis—Vinblastine—head and neck cancer	0.00112	0.00809	CcSEcCtD
Ezetimibe—ANPEP—lymphoid tissue—head and neck cancer	0.0011	0.0374	CbGeAlD
Ezetimibe—Inflammation—Docetaxel—head and neck cancer	0.0011	0.00793	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00108	0.00783	CcSEcCtD
Ezetimibe—Hepatocellular injury—Docetaxel—head and neck cancer	0.00106	0.00769	CcSEcCtD
Ezetimibe—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00106	0.00769	CcSEcCtD
Ezetimibe—SOAT1—thyroid gland—head and neck cancer	0.00105	0.0356	CbGeAlD
Ezetimibe—ANPEP—thyroid gland—head and neck cancer	0.001	0.034	CbGeAlD
Ezetimibe—Alopecia—Vinblastine—head and neck cancer	0.000996	0.0072	CcSEcCtD
Ezetimibe—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000956	0.00691	CcSEcCtD
Ezetimibe—Muscular weakness—Fluorouracil—head and neck cancer	0.000943	0.00682	CcSEcCtD
Ezetimibe—Angiopathy—Hydroxyurea—head and neck cancer	0.000932	0.00674	CcSEcCtD
Ezetimibe—SOAT1—head—head and neck cancer	0.000931	0.0315	CbGeAlD
Ezetimibe—Flunarizine—CYP1A1—head and neck cancer	0.000915	1	CrCbGaD
Ezetimibe—Eosinophilia—Fluorouracil—head and neck cancer	0.000915	0.00662	CcSEcCtD
Ezetimibe—Ill-defined disorder—Vinblastine—head and neck cancer	0.00091	0.00658	CcSEcCtD
Ezetimibe—Alopecia—Hydroxyurea—head and neck cancer	0.000908	0.00657	CcSEcCtD
Ezetimibe—Anaemia—Vinblastine—head and neck cancer	0.000906	0.00656	CcSEcCtD
Ezetimibe—Erythema—Hydroxyurea—head and neck cancer	0.000894	0.00647	CcSEcCtD
Ezetimibe—ANPEP—head—head and neck cancer	0.00089	0.0302	CbGeAlD
Ezetimibe—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000887	0.00642	CcSEcCtD
Ezetimibe—Malaise—Vinblastine—head and neck cancer	0.000884	0.0064	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000859	0.00621	CcSEcCtD
Ezetimibe—Hepatic failure—Docetaxel—head and neck cancer	0.000859	0.00621	CcSEcCtD
Ezetimibe—Hypertension—Vinblastine—head and neck cancer	0.000847	0.00612	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000843	0.0061	CcSEcCtD
Ezetimibe—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00083	0.006	CcSEcCtD
Ezetimibe—Anaemia—Hydroxyurea—head and neck cancer	0.000827	0.00598	CcSEcCtD
Ezetimibe—Discomfort—Vinblastine—head and neck cancer	0.000825	0.00597	CcSEcCtD
Ezetimibe—Hot flush—Docetaxel—head and neck cancer	0.000825	0.00597	CcSEcCtD
Ezetimibe—Infestation NOS—Fluorouracil—head and neck cancer	0.000824	0.00596	CcSEcCtD
Ezetimibe—Infestation—Fluorouracil—head and neck cancer	0.000824	0.00596	CcSEcCtD
Ezetimibe—Menopausal symptoms—Docetaxel—head and neck cancer	0.000818	0.00591	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000807	0.00584	CcSEcCtD
Ezetimibe—Malaise—Hydroxyurea—head and neck cancer	0.000807	0.00583	CcSEcCtD
Ezetimibe—Thrombocytopenia—Vinblastine—head and neck cancer	0.000784	0.00567	CcSEcCtD
Ezetimibe—Sinusitis—Fluorouracil—head and neck cancer	0.000773	0.00559	CcSEcCtD
Ezetimibe—Pain in extremity—Docetaxel—head and neck cancer	0.000772	0.00558	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000756	0.00547	CcSEcCtD
Ezetimibe—Discomfort—Hydroxyurea—head and neck cancer	0.000752	0.00544	CcSEcCtD
Ezetimibe—Pharyngitis—Fluorouracil—head and neck cancer	0.000734	0.00531	CcSEcCtD
Ezetimibe—Infection—Hydroxyurea—head and neck cancer	0.000725	0.00524	CcSEcCtD
Ezetimibe—Paraesthesia—Vinblastine—head and neck cancer	0.000719	0.0052	CcSEcCtD
Ezetimibe—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000716	0.00518	CcSEcCtD
Ezetimibe—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000715	0.00517	CcSEcCtD
Ezetimibe—Liver function test abnormal—Docetaxel—head and neck cancer	0.000712	0.00515	CcSEcCtD
Ezetimibe—Skin disorder—Hydroxyurea—head and neck cancer	0.000709	0.00513	CcSEcCtD
Ezetimibe—Breast disorder—Docetaxel—head and neck cancer	0.000697	0.00504	CcSEcCtD
Ezetimibe—Decreased appetite—Vinblastine—head and neck cancer	0.000696	0.00503	CcSEcCtD
Ezetimibe—Cramp muscle—Docetaxel—head and neck cancer	0.000695	0.00502	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000695	0.00502	CcSEcCtD
Ezetimibe—Nasopharyngitis—Docetaxel—head and neck cancer	0.00069	0.00499	CcSEcCtD
Ezetimibe—Pain—Vinblastine—head and neck cancer	0.000684	0.00495	CcSEcCtD
Ezetimibe—Constipation—Vinblastine—head and neck cancer	0.000684	0.00495	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00068	0.00492	CcSEcCtD
Ezetimibe—Feeling abnormal—Vinblastine—head and neck cancer	0.00066	0.00477	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000654	0.00473	CcSEcCtD
Ezetimibe—Alopecia—Fluorouracil—head and neck cancer	0.000653	0.00473	CcSEcCtD
Ezetimibe—SOAT1—lymph node—head and neck cancer	0.000652	0.0221	CbGeAlD
Ezetimibe—Dyspnoea—Hydroxyurea—head and neck cancer	0.000651	0.00471	CcSEcCtD
Ezetimibe—Erythema—Fluorouracil—head and neck cancer	0.000644	0.00466	CcSEcCtD
Ezetimibe—Dyspepsia—Hydroxyurea—head and neck cancer	0.000643	0.00465	CcSEcCtD
Ezetimibe—Decreased appetite—Hydroxyurea—head and neck cancer	0.000635	0.00459	CcSEcCtD
Ezetimibe—Abdominal pain—Vinblastine—head and neck cancer	0.000633	0.00458	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00063	0.00456	CcSEcCtD
Ezetimibe—Fatigue—Hydroxyurea—head and neck cancer	0.000629	0.00455	CcSEcCtD
Ezetimibe—Pain—Hydroxyurea—head and neck cancer	0.000624	0.00451	CcSEcCtD
Ezetimibe—Constipation—Hydroxyurea—head and neck cancer	0.000624	0.00451	CcSEcCtD
Ezetimibe—ANPEP—lymph node—head and neck cancer	0.000623	0.0211	CbGeAlD
Ezetimibe—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000601	0.00435	CcSEcCtD
Ezetimibe—Anaemia—Fluorouracil—head and neck cancer	0.000595	0.0043	CcSEcCtD
Ezetimibe—Infestation—Docetaxel—head and neck cancer	0.000595	0.0043	CcSEcCtD
Ezetimibe—Infestation NOS—Docetaxel—head and neck cancer	0.000595	0.0043	CcSEcCtD
Ezetimibe—Hypersensitivity—Vinblastine—head and neck cancer	0.00059	0.00426	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000586	0.00395	CbGpPWpGaD
Ezetimibe—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000583	0.00422	CcSEcCtD
Ezetimibe—UGT2B15—Biological oxidations—GSTM1—head and neck cancer	0.000581	0.00392	CbGpPWpGaD
Ezetimibe—Jaundice—Docetaxel—head and neck cancer	0.00058	0.00419	CcSEcCtD
Ezetimibe—Body temperature increased—Hydroxyurea—head and neck cancer	0.000577	0.00417	CcSEcCtD
Ezetimibe—Asthenia—Vinblastine—head and neck cancer	0.000574	0.00415	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000562	0.00407	CcSEcCtD
Ezetimibe—UGT2B15—Biological oxidations—CYP1A1—head and neck cancer	0.000551	0.00372	CbGpPWpGaD
Ezetimibe—Chest pain—Fluorouracil—head and neck cancer	0.000548	0.00396	CcSEcCtD
Ezetimibe—Myalgia—Fluorouracil—head and neck cancer	0.000548	0.00396	CcSEcCtD
Ezetimibe—Diarrhoea—Vinblastine—head and neck cancer	0.000548	0.00396	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—HRAS—head and neck cancer	0.000546	0.00369	CbGpPWpGaD
Ezetimibe—Discomfort—Fluorouracil—head and neck cancer	0.000541	0.00392	CcSEcCtD
Ezetimibe—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000538	0.00389	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—NAT2—head and neck cancer	0.000536	0.00362	CbGpPWpGaD
Ezetimibe—Hepatitis—Docetaxel—head and neck cancer	0.000534	0.00386	CcSEcCtD
Ezetimibe—UGT1A3—Phase II conjugation—GSTM1—head and neck cancer	0.000532	0.00359	CbGpPWpGaD
Ezetimibe—Confusional state—Fluorouracil—head and neck cancer	0.00053	0.00383	CcSEcCtD
Ezetimibe—Pharyngitis—Docetaxel—head and neck cancer	0.00053	0.00383	CcSEcCtD
Ezetimibe—Dizziness—Vinblastine—head and neck cancer	0.000529	0.00383	CcSEcCtD
Ezetimibe—UGT2B7—Metapathway biotransformation—NAT2—head and neck cancer	0.000529	0.00357	CbGpPWpGaD
Ezetimibe—Oedema peripheral—Docetaxel—head and neck cancer	0.000526	0.0038	CcSEcCtD
Ezetimibe—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000525	0.0038	CcSEcCtD
Ezetimibe—Connective tissue disorder—Docetaxel—head and neck cancer	0.000525	0.00379	CcSEcCtD
Ezetimibe—Asthenia—Hydroxyurea—head and neck cancer	0.000524	0.00379	CcSEcCtD
Ezetimibe—Infection—Fluorouracil—head and neck cancer	0.000522	0.00378	CcSEcCtD
Ezetimibe—ABCC3—NRF2 pathway—TGFA—head and neck cancer	0.00052	0.00351	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—TGFA—head and neck cancer	0.00052	0.00351	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Fluorouracil—head and neck cancer	0.000515	0.00373	CcSEcCtD
Ezetimibe—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000514	0.00372	CcSEcCtD
Ezetimibe—Vomiting—Vinblastine—head and neck cancer	0.000509	0.00368	CcSEcCtD
Ezetimibe—Erythema multiforme—Docetaxel—head and neck cancer	0.000505	0.00365	CcSEcCtD
Ezetimibe—Headache—Vinblastine—head and neck cancer	0.000501	0.00363	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000501	0.00338	CbGpPWpGaD
Ezetimibe—ABCC3—thyroid gland—head and neck cancer	0.0005	0.0169	CbGeAlD
Ezetimibe—Diarrhoea—Hydroxyurea—head and neck cancer	0.000499	0.00361	CcSEcCtD
Ezetimibe—ABCG2—parotid gland—head and neck cancer	0.000499	0.0169	CbGeAlD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000496	0.00335	CbGpPWpGaD
Ezetimibe—Flushing—Docetaxel—head and neck cancer	0.000495	0.00358	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—UROD—head and neck cancer	0.000485	0.00327	CbGpPWpGaD
Ezetimibe—Angiopathy—Docetaxel—head and neck cancer	0.000484	0.0035	CcSEcCtD
Ezetimibe—Dizziness—Hydroxyurea—head and neck cancer	0.000483	0.00349	CcSEcCtD
Ezetimibe—Immune system disorder—Docetaxel—head and neck cancer	0.000482	0.00349	CcSEcCtD
Ezetimibe—Mediastinal disorder—Docetaxel—head and neck cancer	0.000481	0.00348	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000479	0.00346	CcSEcCtD
Ezetimibe—ABCG2—saliva-secreting gland—head and neck cancer	0.000478	0.0162	CbGeAlD
Ezetimibe—Nausea—Vinblastine—head and neck cancer	0.000475	0.00344	CcSEcCtD
Ezetimibe—Insomnia—Fluorouracil—head and neck cancer	0.000475	0.00344	CcSEcCtD
Ezetimibe—Paraesthesia—Fluorouracil—head and neck cancer	0.000472	0.00341	CcSEcCtD
Ezetimibe—Alopecia—Docetaxel—head and neck cancer	0.000472	0.00341	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—NAT2—head and neck cancer	0.000471	0.00318	CbGpPWpGaD
Ezetimibe—Dyspnoea—Fluorouracil—head and neck cancer	0.000468	0.00339	CcSEcCtD
Ezetimibe—Mental disorder—Docetaxel—head and neck cancer	0.000468	0.00338	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000467	0.00315	CbGpPWpGaD
Ezetimibe—Erythema—Docetaxel—head and neck cancer	0.000465	0.00336	CcSEcCtD
Ezetimibe—Malnutrition—Docetaxel—head and neck cancer	0.000465	0.00336	CcSEcCtD
Ezetimibe—Vomiting—Hydroxyurea—head and neck cancer	0.000464	0.00336	CcSEcCtD
Ezetimibe—Dyspepsia—Fluorouracil—head and neck cancer	0.000462	0.00334	CcSEcCtD
Ezetimibe—Rash—Hydroxyurea—head and neck cancer	0.00046	0.00333	CcSEcCtD
Ezetimibe—Dermatitis—Hydroxyurea—head and neck cancer	0.00046	0.00333	CcSEcCtD
Ezetimibe—Headache—Hydroxyurea—head and neck cancer	0.000457	0.00331	CcSEcCtD
Ezetimibe—Decreased appetite—Fluorouracil—head and neck cancer	0.000457	0.0033	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000454	0.00328	CcSEcCtD
Ezetimibe—UGT2B7—Phase II conjugation—GSTM1—head and neck cancer	0.000452	0.00306	CbGpPWpGaD
Ezetimibe—Back pain—Docetaxel—head and neck cancer	0.000449	0.00325	CcSEcCtD
Ezetimibe—Pain—Fluorouracil—head and neck cancer	0.000449	0.00325	CcSEcCtD
Ezetimibe—Muscle spasms—Docetaxel—head and neck cancer	0.000447	0.00323	CcSEcCtD
Ezetimibe—ABCC3—head—head and neck cancer	0.000444	0.015	CbGeAlD
Ezetimibe—UGT1A1—Biological oxidations—NAT2—head and neck cancer	0.000436	0.00294	CbGpPWpGaD
Ezetimibe—Nausea—Hydroxyurea—head and neck cancer	0.000434	0.00314	CcSEcCtD
Ezetimibe—Feeling abnormal—Fluorouracil—head and neck cancer	0.000433	0.00313	CcSEcCtD
Ezetimibe—UGT1A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00043	0.0029	CbGpPWpGaD
Ezetimibe—Anaemia—Docetaxel—head and neck cancer	0.000429	0.00311	CcSEcCtD
Ezetimibe—UGT1A1—NRF2 pathway—TGFA—head and neck cancer	0.000422	0.00285	CbGpPWpGaD
Ezetimibe—Urticaria—Fluorouracil—head and neck cancer	0.000417	0.00302	CcSEcCtD
Ezetimibe—Body temperature increased—Fluorouracil—head and neck cancer	0.000415	0.003	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—DPYD—head and neck cancer	0.000413	0.00279	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—TGFA—head and neck cancer	0.000412	0.00278	CbGpPWpGaD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000412	0.00278	CbGpPWpGaD
Ezetimibe—Palpitations—Docetaxel—head and neck cancer	0.000411	0.00297	CcSEcCtD
Ezetimibe—Cough—Docetaxel—head and neck cancer	0.000405	0.00293	CcSEcCtD
Ezetimibe—Hypertension—Docetaxel—head and neck cancer	0.000401	0.0029	CcSEcCtD
Ezetimibe—Myalgia—Docetaxel—head and neck cancer	0.000396	0.00286	CcSEcCtD
Ezetimibe—Chest pain—Docetaxel—head and neck cancer	0.000396	0.00286	CcSEcCtD
Ezetimibe—Arthralgia—Docetaxel—head and neck cancer	0.000396	0.00286	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000393	0.00284	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—YAP1—head and neck cancer	0.000392	0.00265	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Fluorouracil—head and neck cancer	0.000387	0.0028	CcSEcCtD
Ezetimibe—Dry mouth—Docetaxel—head and neck cancer	0.000387	0.0028	CcSEcCtD
Ezetimibe—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000385	0.0026	CbGpPWpGaD
Ezetimibe—Confusional state—Docetaxel—head and neck cancer	0.000382	0.00277	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000379	0.00256	CbGpPWpGaD
Ezetimibe—Anaphylactic shock—Docetaxel—head and neck cancer	0.000379	0.00274	CcSEcCtD
Ezetimibe—Infection—Docetaxel—head and neck cancer	0.000377	0.00272	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000376	0.00254	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Docetaxel—head and neck cancer	0.000372	0.00269	CcSEcCtD
Ezetimibe—Pruritus—Fluorouracil—head and neck cancer	0.000372	0.00269	CcSEcCtD
Ezetimibe—Thrombocytopenia—Docetaxel—head and neck cancer	0.000371	0.00269	CcSEcCtD
Ezetimibe—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00037	0.0025	CbGpPWpGaD
Ezetimibe—Skin disorder—Docetaxel—head and neck cancer	0.000368	0.00266	CcSEcCtD
Ezetimibe—UGT1A1—Phase II conjugation—GSTM1—head and neck cancer	0.000368	0.00248	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000365	0.00247	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000362	0.00244	CbGpPWpGaD
Ezetimibe—Diarrhoea—Fluorouracil—head and neck cancer	0.000359	0.0026	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000357	0.00241	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—NAT2—head and neck cancer	0.000357	0.00241	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—GSTM1—head and neck cancer	0.000355	0.0024	CbGpPWpGaD
Ezetimibe—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000351	0.00237	CbGpPWpGaD
Ezetimibe—Dizziness—Fluorouracil—head and neck cancer	0.000347	0.00251	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000345	0.0025	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—NAT2—head and neck cancer	0.000344	0.00232	CbGpPWpGaD
Ezetimibe—Insomnia—Docetaxel—head and neck cancer	0.000343	0.00248	CcSEcCtD
Ezetimibe—Paraesthesia—Docetaxel—head and neck cancer	0.000341	0.00246	CcSEcCtD
Ezetimibe—Dyspnoea—Docetaxel—head and neck cancer	0.000338	0.00245	CcSEcCtD
Ezetimibe—Vomiting—Fluorouracil—head and neck cancer	0.000334	0.00242	CcSEcCtD
Ezetimibe—Dyspepsia—Docetaxel—head and neck cancer	0.000334	0.00241	CcSEcCtD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000333	0.00225	CbGpPWpGaD
Ezetimibe—Rash—Fluorouracil—head and neck cancer	0.000331	0.0024	CcSEcCtD
Ezetimibe—Dermatitis—Fluorouracil—head and neck cancer	0.000331	0.00239	CcSEcCtD
Ezetimibe—Decreased appetite—Docetaxel—head and neck cancer	0.00033	0.00238	CcSEcCtD
Ezetimibe—Headache—Fluorouracil—head and neck cancer	0.000329	0.00238	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000327	0.00237	CcSEcCtD
Ezetimibe—Fatigue—Docetaxel—head and neck cancer	0.000327	0.00236	CcSEcCtD
Ezetimibe—Pain—Docetaxel—head and neck cancer	0.000324	0.00235	CcSEcCtD
Ezetimibe—Constipation—Docetaxel—head and neck cancer	0.000324	0.00235	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000323	0.00218	CbGpPWpGaD
Ezetimibe—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000322	0.00218	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—DPYD—head and neck cancer	0.000313	0.00212	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Docetaxel—head and neck cancer	0.000312	0.00226	CcSEcCtD
Ezetimibe—Nausea—Fluorouracil—head and neck cancer	0.000312	0.00226	CcSEcCtD
Ezetimibe—UGT1A3—Biological oxidations—GSTM1—head and neck cancer	0.000311	0.0021	CbGpPWpGaD
Ezetimibe—ABCC3—lymph node—head and neck cancer	0.000311	0.0105	CbGeAlD
Ezetimibe—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00031	0.00224	CcSEcCtD
Ezetimibe—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00031	0.00209	CbGpPWpGaD
Ezetimibe—UGT1A3—Metapathway biotransformation—GSTM1—head and neck cancer	0.000307	0.00207	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—GSTM1—head and neck cancer	0.000302	0.00204	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—GSTM1—head and neck cancer	0.000302	0.00204	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—DPYD—head and neck cancer	0.000302	0.00204	CbGpPWpGaD
Ezetimibe—Abdominal pain—Docetaxel—head and neck cancer	0.0003	0.00217	CcSEcCtD
Ezetimibe—Body temperature increased—Docetaxel—head and neck cancer	0.0003	0.00217	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—YAP1—head and neck cancer	0.000297	0.00201	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—VEGFA—head and neck cancer	0.000296	0.002	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—CYP1A1—head and neck cancer	0.000295	0.00199	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000295	0.00199	CbGpPWpGaD
Ezetimibe—ABCG2—thyroid gland—head and neck cancer	0.000291	0.00988	CbGeAlD
Ezetimibe—UGT1A3—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000291	0.00197	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—YAP1—head and neck cancer	0.000286	0.00193	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Docetaxel—head and neck cancer	0.000279	0.00202	CcSEcCtD
Ezetimibe—Asthenia—Docetaxel—head and neck cancer	0.000272	0.00197	CcSEcCtD
Ezetimibe—Pruritus—Docetaxel—head and neck cancer	0.000268	0.00194	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—GSTM1—head and neck cancer	0.000265	0.00179	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000261	0.00176	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—UROD—head and neck cancer	0.00026	0.00175	CbGpPWpGaD
Ezetimibe—Diarrhoea—Docetaxel—head and neck cancer	0.000259	0.00188	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000257	0.00174	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—CYP1A1—head and neck cancer	0.000251	0.00169	CbGpPWpGaD
Ezetimibe—Dizziness—Docetaxel—head and neck cancer	0.000251	0.00181	CcSEcCtD
Ezetimibe—ABCC2—lymph node—head and neck cancer	0.000248	0.00841	CbGeAlD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000248	0.00167	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000248	0.00167	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000247	0.00167	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—GSTM1—head and neck cancer	0.000245	0.00166	CbGpPWpGaD
Ezetimibe—Vomiting—Docetaxel—head and neck cancer	0.000241	0.00174	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—GSTM1—head and neck cancer	0.000239	0.00162	CbGpPWpGaD
Ezetimibe—Rash—Docetaxel—head and neck cancer	0.000239	0.00173	CcSEcCtD
Ezetimibe—Dermatitis—Docetaxel—head and neck cancer	0.000239	0.00173	CcSEcCtD
Ezetimibe—Headache—Docetaxel—head and neck cancer	0.000238	0.00172	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—TYMS—head and neck cancer	0.000236	0.00159	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GSTM1—head and neck cancer	0.000233	0.00157	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000229	0.00155	CbGpPWpGaD
Ezetimibe—Nausea—Docetaxel—head and neck cancer	0.000225	0.00163	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000223	0.00151	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GPX1—head and neck cancer	0.000223	0.00151	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—UROD—head and neck cancer	0.000221	0.00149	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CYP1A1—head and neck cancer	0.000221	0.00149	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—UROD—head and neck cancer	0.000221	0.00149	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—GSTM1—head and neck cancer	0.000215	0.00145	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000215	0.00145	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000212	0.00143	CbGpPWpGaD
Ezetimibe—ABCB1—epithelium—head and neck cancer	0.000205	0.00696	CbGeAlD
Ezetimibe—UGT1A1—Biological oxidations—CYP1A1—head and neck cancer	0.000204	0.00138	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—NAT2—head and neck cancer	0.000201	0.00136	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000201	0.00136	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000196	0.00133	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000195	0.00132	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000188	0.00127	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000184	0.00124	CbGpPWpGaD
Ezetimibe—ABCB1—trachea—head and neck cancer	0.000182	0.00616	CbGeAlD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000181	0.00122	CbGpPWpGaD
Ezetimibe—ABCG2—lymph node—head and neck cancer	0.000181	0.00613	CbGeAlD
Ezetimibe—UGT1A1—Metabolism—UROD—head and neck cancer	0.000179	0.00121	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—TYMS—head and neck cancer	0.000179	0.00121	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GSTM1—head and neck cancer	0.000176	0.00119	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—DPYD—head and neck cancer	0.000176	0.00119	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000174	0.00118	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—TYMS—head and neck cancer	0.000172	0.00116	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000171	0.00116	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000171	0.00115	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GSTM1—head and neck cancer	0.00017	0.00115	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GPX1—head and neck cancer	0.000169	0.00114	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000168	0.00113	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—YAP1—head and neck cancer	0.000167	0.00113	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CYP1A1—head and neck cancer	0.000167	0.00113	CbGpPWpGaD
Ezetimibe—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000166	0.00112	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—UROD—head and neck cancer	0.000164	0.00111	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GPX1—head and neck cancer	0.000163	0.0011	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CYP1A1—head and neck cancer	0.000161	0.00109	CbGpPWpGaD
Ezetimibe—ABCB1—lymphoid tissue—head and neck cancer	0.000158	0.00536	CbGeAlD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000153	0.00103	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—UROD—head and neck cancer	0.000152	0.00103	CbGpPWpGaD
Ezetimibe—ABCB1—thyroid gland—head and neck cancer	0.000144	0.00487	CbGeAlD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000137	0.000928	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000134	0.000904	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000132	0.000893	CbGpPWpGaD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000132	0.000892	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTGS2—head and neck cancer	0.000131	0.000886	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000128	0.000861	CbGpPWpGaD
Ezetimibe—ABCB1—head—head and neck cancer	0.000127	0.00432	CbGeAlD
Ezetimibe—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000127	0.000859	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000123	0.000831	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000121	0.00082	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTEN—head and neck cancer	0.000114	0.000773	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000111	0.000751	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000108	0.000733	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NAT2—head and neck cancer	0.000108	0.000728	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—TYMS—head and neck cancer	0.000101	0.000679	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTGS2—head and neck cancer	9.95e-05	0.000672	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTM1—head and neck cancer	9.94e-05	0.000671	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.73e-05	0.000657	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.64e-05	0.000651	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2—head and neck cancer	9.61e-05	0.000649	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—head and neck cancer	9.58e-05	0.000647	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GPX1—head and neck cancer	9.52e-05	0.000643	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DPYD—head and neck cancer	9.45e-05	0.000638	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	9.43e-05	0.000637	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP1A1—head and neck cancer	9.42e-05	0.000636	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.23e-05	0.000623	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	9.18e-05	0.00062	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NAT2—head and neck cancer	9.17e-05	0.000619	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NAT2—head and neck cancer	9.17e-05	0.000619	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—YAP1—head and neck cancer	8.97e-05	0.000606	CbGpPWpGaD
Ezetimibe—ABCB1—lymph node—head and neck cancer	8.93e-05	0.00303	CbGeAlD
Ezetimibe—ABCG8—Metabolism—PTEN—head and neck cancer	8.68e-05	0.000586	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTEN—head and neck cancer	8.35e-05	0.000564	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—UROD—head and neck cancer	8.23e-05	0.000556	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	8.17e-05	0.000551	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PIK3CA—head and neck cancer	8.08e-05	0.000545	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DPYD—head and neck cancer	8.04e-05	0.000543	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DPYD—head and neck cancer	8.04e-05	0.000543	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—YAP1—head and neck cancer	7.63e-05	0.000515	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—YAP1—head and neck cancer	7.63e-05	0.000515	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NAT2—head and neck cancer	7.45e-05	0.000503	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.25e-05	0.000489	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.18e-05	0.000485	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NAT2—head and neck cancer	6.83e-05	0.000461	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AKT1—head and neck cancer	6.6e-05	0.000445	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DPYD—head and neck cancer	6.53e-05	0.000441	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NAT2—head and neck cancer	6.32e-05	0.000427	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.28e-05	0.000424	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—YAP1—head and neck cancer	6.2e-05	0.000418	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CA—head and neck cancer	6.12e-05	0.000413	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	6.08e-05	0.000411	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	6.02e-05	0.000406	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	6e-05	0.000405	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DPYD—head and neck cancer	5.98e-05	0.000404	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CA—head and neck cancer	5.89e-05	0.000398	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.76e-05	0.000389	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.73e-05	0.000387	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.68e-05	0.000384	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—YAP1—head and neck cancer	5.68e-05	0.000383	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—head and neck cancer	5.6e-05	0.000378	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DPYD—head and neck cancer	5.54e-05	0.000374	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TYMS—head and neck cancer	5.39e-05	0.000364	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.39e-05	0.000364	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTM1—head and neck cancer	5.32e-05	0.00036	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—YAP1—head and neck cancer	5.26e-05	0.000355	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5.12e-05	0.000345	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GPX1—head and neck cancer	5.1e-05	0.000344	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UROD—head and neck cancer	5.07e-05	0.000342	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP1A1—head and neck cancer	5.05e-05	0.000341	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—head and neck cancer	5e-05	0.000338	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5e-05	0.000337	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTEN—head and neck cancer	4.89e-05	0.00033	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—head and neck cancer	4.81e-05	0.000325	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.62e-05	0.000312	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TYMS—head and neck cancer	4.58e-05	0.000309	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TYMS—head and neck cancer	4.58e-05	0.000309	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTM1—head and neck cancer	4.53e-05	0.000306	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTM1—head and neck cancer	4.53e-05	0.000306	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.46e-05	0.000301	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GPX1—head and neck cancer	4.34e-05	0.000293	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GPX1—head and neck cancer	4.34e-05	0.000293	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP1A1—head and neck cancer	4.29e-05	0.00029	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP1A1—head and neck cancer	4.29e-05	0.00029	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.27e-05	0.000288	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.03e-05	0.000272	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.81e-05	0.000257	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TYMS—head and neck cancer	3.72e-05	0.000251	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.72e-05	0.000251	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—head and neck cancer	3.68e-05	0.000248	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.63e-05	0.000245	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.63e-05	0.000245	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.53e-05	0.000238	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX1—head and neck cancer	3.52e-05	0.000238	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP1A1—head and neck cancer	3.49e-05	0.000235	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—head and neck cancer	3.45e-05	0.000233	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NAT2—head and neck cancer	3.42e-05	0.000231	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TYMS—head and neck cancer	3.41e-05	0.00023	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—head and neck cancer	3.37e-05	0.000228	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX1—head and neck cancer	3.23e-05	0.000218	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	3.2e-05	0.000216	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TYMS—head and neck cancer	3.16e-05	0.000213	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.15e-05	0.000213	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—head and neck cancer	3.12e-05	0.000211	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.04e-05	0.000206	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—head and neck cancer	3e-05	0.000203	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DPYD—head and neck cancer	3e-05	0.000202	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX1—head and neck cancer	2.99e-05	0.000202	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP1A1—head and neck cancer	2.96e-05	0.0002	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—YAP1—head and neck cancer	2.84e-05	0.000192	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—head and neck cancer	2.82e-05	0.00019	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.63e-05	0.000177	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—head and neck cancer	2.62e-05	0.000177	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.57e-05	0.000174	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—head and neck cancer	2.55e-05	0.000172	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—head and neck cancer	2.55e-05	0.000172	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—head and neck cancer	2.23e-05	0.00015	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—head and neck cancer	2.23e-05	0.00015	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NAT2—head and neck cancer	2.11e-05	0.000142	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—head and neck cancer	2.07e-05	0.00014	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—head and neck cancer	1.9e-05	0.000128	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—head and neck cancer	1.85e-05	0.000125	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DPYD—head and neck cancer	1.85e-05	0.000125	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—head and neck cancer	1.81e-05	0.000122	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—head and neck cancer	1.76e-05	0.000119	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—YAP1—head and neck cancer	1.75e-05	0.000118	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TYMS—head and neck cancer	1.71e-05	0.000115	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—head and neck cancer	1.69e-05	0.000114	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—head and neck cancer	1.66e-05	0.000112	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX1—head and neck cancer	1.62e-05	0.000109	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.6e-05	0.000108	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—head and neck cancer	1.57e-05	0.000106	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—head and neck cancer	1.57e-05	0.000106	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—head and neck cancer	1.53e-05	0.000104	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—head and neck cancer	1.51e-05	0.000102	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—head and neck cancer	1.28e-05	8.66e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—head and neck cancer	1.28e-05	8.66e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—head and neck cancer	1.28e-05	8.62e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	1.17e-05	7.89e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.08e-05	7.31e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TYMS—head and neck cancer	1.05e-05	7.1e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—head and neck cancer	1.04e-05	7.04e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.04e-05	7.02e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX1—head and neck cancer	9.96e-06	6.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.86e-06	6.66e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—head and neck cancer	9.55e-06	6.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—head and neck cancer	9.51e-06	6.42e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—head and neck cancer	8.84e-06	5.97e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—head and neck cancer	8.3e-06	5.6e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.86e-06	3.96e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.85e-06	3.95e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—head and neck cancer	5.11e-06	3.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—head and neck cancer	4.78e-06	3.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.61e-06	2.43e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—head and neck cancer	2.95e-06	1.99e-05	CbGpPWpGaD
